Therapeutic gene silencing of


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
05 04 2023
Historique:
medline: 7 4 2023
entrez: 5 4 2023
pubmed: 6 4 2023
Statut: ppublish

Résumé

The potential of microtubule-associated protein targets for cancer therapeutics remains largely unexplored due to the lack of target-specific agents. Here, we explored the therapeutic potential of targeting cytoskeleton-associated protein 5 (CKAP5), an important microtubule-associated protein, with

Identifiants

pubmed: 37018392
doi: 10.1126/sciadv.ade4800
pmc: PMC10075965
doi:

Substances chimiques

Microtubule-Associated Proteins 0
RNA, Small Interfering 0
CKAP5 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eade4800

Références

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8315-20
pubmed: 15914550
Nat Rev Cancer. 2003 Jul;3(7):502-16
pubmed: 12835670
J Clin Oncol. 2014 May 1;32(13):1302-8
pubmed: 24637997
Int J Oncol. 2017 Feb;50(2):365-372
pubmed: 28101582
Mol Biol Cell. 2004 Apr;15(4):1580-90
pubmed: 14718566
Cell. 2016 Jun 2;165(6):1428-1439
pubmed: 27156448
Nat Cell Biol. 2018 May;20(5):575-585
pubmed: 29695792
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Cancer Res. 2020 Nov 15;80(22):4946-4959
pubmed: 32998996
Mol Cell Biol. 2008 Dec;28(23):7199-211
pubmed: 18809577
Cancer Res. 2012 Feb 1;72(3):757-68
pubmed: 22147262
Cold Spring Harb Protoc. 2009 Dec;2009(12):pdb.top63
pubmed: 20150100
Oncogene. 2011 Feb 3;30(5):521-34
pubmed: 20838383
Nanotechnol Sci Appl. 2012 Sep 07;5:87-100
pubmed: 24198499
Nat Cell Biol. 2015 Nov;17(11):1422-34
pubmed: 26414402
Am J Pathol. 2005 Jun;166(6):1841-50
pubmed: 15920168
Cold Spring Harb Perspect Biol. 2018 Jun 1;10(6):
pubmed: 29858272
Angew Chem Int Ed Engl. 2012 Aug 20;51(34):8529-33
pubmed: 22782619
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Cell Biol. 2001 Sep 17;154(6):1125-33
pubmed: 11564753
Biochem Pharmacol. 2021 Jul;189:114432
pubmed: 33513339
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Mol Cell. 2015 Nov 19;60(4):524-36
pubmed: 26590712
Front Cell Dev Biol. 2021 Feb 09;9:635511
pubmed: 33634136
Clin Cancer Res. 2007 May 15;13(10):2849-54
pubmed: 17504982
Neuropharmacology. 2014 Jan;76 Pt A:175-83
pubmed: 23978385
N Engl J Med. 2018 Jul 5;379(1):11-21
pubmed: 29972753
Anticancer Res. 2001 Jul-Aug;21(4A):2537-45
pubmed: 11724319
Adv Mater. 2020 Mar;32(12):e1906128
pubmed: 31999380
Cancer Res. 2004 May 1;64(9):3276-80
pubmed: 15126370
Front Oncol. 2013 Oct 01;3:237
pubmed: 24098868
Oncogene. 2008 Nov 20;27(51):6539-49
pubmed: 18663358
Nat Cell Biol. 2018 Mar;20(3):252-261
pubmed: 29379139
Nat Rev Cancer. 2004 Apr;4(4):253-65
pubmed: 15057285
N Engl J Med. 2006 Jan 5;354(1):34-43
pubmed: 16394300
Cell Stem Cell. 2009 Nov 6;5(5):515-26
pubmed: 19896442

Auteurs

Sushmita Chatterjee (S)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

Gonna Somu Naidu (GS)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

Inbal Hazan-Halevy (I)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

Hanna Grobe (H)

Department of Cell and Developmental Biology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Assaf Ezra (A)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

Preeti Sharma (P)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

Meir Goldsmith (M)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

Srinivas Ramishetti (S)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

David Sprinzak (D)

School of Neurobiology, Biochemistry and Biophysics, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.

Ronen Zaidel-Bar (R)

Department of Cell and Developmental Biology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dan Peer (D)

Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel.
Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH